They validated the nonrandom expression of PDPN among GBM cells and its correlation with cell subpopulations enriched in mesenchymal differentiation signatures, cancer-related inflammation, and coagulation-associated genes [96]. The gene discussed is PDPN; the disease is glioblastoma.